The United States Food and Drug Administration (FDA) has granted Medtronic Inc. clearance for marketing for their biliary stent system for the treatment of malignancies of the bile duct.
Medtronic Inc.’s medical device will be marketed under the name Complete SE (self-expanding) Biliary Stent System.
Commercial sales within the United States will begin immediately, according to Medtronic Inc.
© 1998-2007 OncoEd.com All Rights Reserved.
These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers should verify all information and data before administering any drug, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.